UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000032646
Receipt number R000037225
Scientific Title Multicenter Prospective Observational Registry of Delirium
Date of disclosure of the study information 2018/05/19
Last modified on 2019/11/03 23:52:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter Prospective Observational Registry of Delirium

Acronym

Delirium Registry

Scientific Title

Multicenter Prospective Observational Registry of Delirium

Scientific Title:Acronym

Delirium Registry

Region

Japan


Condition

Condition

Delirium

Classification by specialty

Medicine in general Surgery in general Psychiatry
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate epidemiology of delirium in a variety of medical conditions

Basic objectives2

Others

Basic objectives -Others

To investigate epidemiology of delirium in a variety of medical conditions

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To investigate epidemiology of delirium in a variety of medical conditions

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

120 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with delirium or those who has possibility to become delirium

Key exclusion criteria

N/A

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahiko Hara, MD, PhD

Organization

Japan Society of Clinical Research

Division name

Department of Clinical Investigation

Zip code


Address

Kita-ku Umeda 1-11-1000 Osaka Ekimae 4th Bldg 10F Osaka, 530-0001 Japan

TEL

0661315495

Email

hara@japanscr.org


Public contact

Name of contact person

1st name
Middle name
Last name Masahiko Hara, MD, PhD

Organization

Japan Society of Clinical Research

Division name

Department of Clinical Investigation

Zip code


Address

Kita-ku Umeda 1-11-1000 Osaka Ekimae 4th Bldg 10F Osaka, 530-0001 Japan

TEL

0661315495

Homepage URL

https://www.japanscr.org/

Email

hara@japanscr.org


Sponsor or person

Institute

Japan Society of Clinical Research

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 27 Day

Date of IRB

2017 Year 07 Month 27 Day

Anticipated trial start date

2017 Year 11 Month 08 Day

Last follow-up date

2019 Year 11 Month 07 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Primary endpoint: Incidence of Delirium
Secondary endpoint: Total mortality, duration of hospitalization, etc


Management information

Registered date

2018 Year 05 Month 19 Day

Last modified on

2019 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037225


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name